![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Hamaue N. Minami M. Terado M. Hirafuji M. Endo T. Machida M. Hiroshige T. Ogata A. Tashiro K. Saito H. Parvez S.H.
Publisher: Elsevier
ISSN: 0161-813X
Source: Neurotoxicology, Vol.25, Iss.1, 2004-01, pp. : 205-213
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Safety of Selegiline (Deprenyl) in the Treatment of Parkinson's Disease
Drug Safety, Vol. 19, Iss. 1, 1998-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Fentanyl: Bradykinesia and rigidity in a patient with Parkinson's disease: case report
Reactions Weekly, Vol. 1, Iss. 1242, 2009-01 ,pp. :